Peter Ashley Marks

Alterity Therapeutics Ltd

Insider activity · 24 months1 buy0 salesCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 1 buy · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€21k

▼ Sales (0 ops.)

—

Latest filing published 08 Sept 2026 for ALTERITY THERAPEUTICS LTD, €21k.

Filing timeline

BuySale

Peter Ashley Marks

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Peter Ashley Marks: trading record in brief

Our data holds just one disclosure by Peter Ashley Marks, dated 8 September 2026, reporting an open-market purchase worth €21k in Alterity Therapeutics Ltd. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Peter Ashley Marks

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Alterity Therapeutics Ltd (US)

Declarations1 total

▲
Peter Ashley Marks
DirectorExecutives31 Aug 2026Alterity Therapeutics Ltd
23,810 USD0SEC
47,620 shares@ US$0.50Ordinary sharesSEC:0002127888-26-000004:0
Canonical exit: 29 Nov 2026 (T+90)

1 of 1 declaration

Peter Ashley Marks

Insider track record

Peter Ashley Marks: trading record in brief

Companies and markets linked to Peter Ashley Marks

Related entities